Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ranibizumab, Atc S01La04 (Obo) For The Period 01.09.2024 - 31.08.2026
Deadline - Jul 05, 2026
GT reference number - 18915757
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 18915757
Document Type - Tender Notices
Description - Description: Section 130a paragraph 8 of the Social Code Book V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of the statutory health insurance compani es. In view of the relevant legal provisions for the award of public contracts, a regular process of active substance-related, formal award procedures takes place through DAK-Gesundheit in accordance with the regulations of Part 4 of the GWB. For drugs containing the above-mentioned active substance, Ranibizumab, ATC S01LA04, which are to be specified by the bidder in Annex 2 to the contract, DAK-Gesundheit intends to conclude drug discount agree
Gt Ref Id - 18915757
Deadline - Jul 05, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database